Trials / Conditions / Alzheimer's Disease Psychosis
Alzheimer's Disease Psychosis
7 registered clinical trials studyying Alzheimer's Disease Psychosis — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Phase 1 MAD Study to Evaluate the Safety and Tolerability of LY03020 NCT07230652 | Luye Pharma Group Ltd. | Phase 1 |
| Active Not Recruiting | A Food Effect Study of LY03020 in Healthy Subjects NCT07292233 | Luye Pharma Group Ltd. | Phase 1 |
| Not Yet Recruiting | Effect of Food and Age on the Pharmacokinetics of LY03017 NCT06793995 | Luye Pharma Group Ltd. | Phase 1 |
| Completed | A Study Assessing the Safety and Tolerability of LY03020 in Chinese Healthy Subjects NCT06556966 | Luye Pharma Group Ltd. | Phase 1 |
| Enrolling By Invitation | ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study NCT06194799 | ACADIA Pharmaceuticals Inc. | Phase 3 |
| Recruiting | ACP-204 in Adults With Alzheimer's Disease Psychosis NCT06159673 | ACADIA Pharmaceuticals Inc. | Phase 2 / Phase 3 |
| Completed | A Study of the Safety and Efficacy of Pimavanserin in Patients With Alzheimer's Disease Psychosis NCT02035553 | ACADIA Pharmaceuticals Inc. | Phase 2 |